Abstract:Preeclampsia (PE) is a complex pregnancy-related hypertensive disorder leading to multiorgan dysfunction. It has high maternal, fetal, and neonatal morbidity and mortality rates. The study of gut microbiota and its metabolites in PE deserves further exploration. Thirty-eight pregnant women with PE and 29 healthy pregnant women in the third trimester of their pregnancy were recruited in this study. We used a targeted metabolomics approach to evaluate the short-chain fatty acids (SCFAs) in serum samples. The correlation between SCFAs and clinical characteristics was also explored. The results of mass spectrometry (MS) showed significant differences at the metabolomics level of SCFAs between the PE and healthy control. The metabolic levels of acetate, propionate, isobutyrate, and valerate were significantly increased in the PE group than in the healthy control group. In contrast, caproic acid and butyrate levels were significantly reduced. The correlation analysis showed that urea, systolic, and diastolic blood pressure levels were positively correlated with four types of SCFAs (acetic acid, propionic acid, isobutyric acid, and valeric acid) which increased in the PE group. Furthermore, the neutrophil percentage and the fetal birth weight were negatively correlated with isobutyric acid and valeric acid. In addition, the receiver operating characteristic (ROC) analysis using a generalized linear model showed that multiple SCFAs would be potential diagnostic markers for PE, with high specificity, sensitivity, and area under the curve (AUC). Among them, isobutyric acid (sensitivity: 97.4%, specificity: 100%, AUC = 1.00), propionic acid (sensitivity: 86.8%, specificity: 93.3%, AUC = 0.954) and acetic acid (sensitivity: 86.8%, specificity: 83.3%, AUC = 0.891) depicted significantly higher diagnostic value and potential clinical applications. In summary, the results of this study indicate that SCFAs have the potential to become effective biomarkers for early screening of PE.

One-step Preparation of Boronic Acid-Rich Hydrothermal Spheres for N-glycopeptide Analysis from Preeclampsia Serum.

Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth

Comparative peptidomics analysis of preeclamptic placenta and the identification of a novel bioactive SERPINA1 C-terminal peptide

Proteomic analysis of human serum for Finding pathogenic factors and potential biomarkers in preeclampsia

Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies

Serum markers of pre-eclampsia identified on proteomics.

Isobaric tag for relative and absolute quantitation based quantitative proteomics reveals unique urinary protein profiles in patients with preeclampsia

One-step Preparation of Magnetic Zwitterionic-Hydrophilic Dual Functional Nanospheres for In-Depth Glycopeptides Analysis in Alzheimer's Disease Patients' Serum

Fibrinogen beta chain may be a potential predict biomarker for pre-eclampsia: A preliminary study

Proteomics Analysis of Differential Protein Expression in Serum of Pregnant Women with Preeclampsia and Acute Phase Protein

The Diagnostic Potential of Gut Microbiota-Derived Short-Chain Fatty Acids in Preeclampsia

Disaccharide compositional analysis of chondroitin sulphate using WAX HILIC-MS with pre-column procainamide labelling; application to the placenta in pre-eclampsia

Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China

Enhancing Pregnancy Care: Harnessing Label‐Free Immunosensors for Pre‐Eclampsia Detection Using PdNPs/Poly(3,5‐Diaminobenzoic Acid) Modified Glassy Carbon Electrodes

Bowtie Nanoantenna LSPR Biosensor for Early Prediction of Preeclampsia

Screening and Functional Analysis of the Differential Peptides from the Placenta of Patients with Healthy Pregnancy and Preeclampsia Using Placental Peptidome

Active metabolomics identify potential functional metabolites for preeclampsia prevention

Proteomic Analysis of Preeclampsia Amniotic Fluid Based on a Novel Solid-State Preservation Method

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia

IGFBP1 and Routine Laboratory Indicators for Early Prediction of Pre-Eclampsia in Chinese Population